Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System
Wound care professionals across multiple specialties to support strategic alignment of patient, payor, and provider…
Month: January 2023
Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System
Wound care professionals across multiple specialties to support strategic alignment of patient, payor, and provider…
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
Preliminary full year revenue for 2022 of approximately $ 2.7 million is within most recent…
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
Preliminary full year revenue for 2022 of approximately $ 2.7 million is within most recent…
SciSparc Receives Approval to Conduct its Clinical Trial in Children with Autism Spectrum Disorder at the Soroka Medical Center
The Company has already secured approvals from Ethics Committee and Israeli Ministry of Health for the Company’s study with its proprietary SCI-210 treatment…
SciSparc Receives Approval to Conduct its Clinical Trial in Children with Autism Spectrum Disorder at the Soroka Medical Center
The Company has already secured approvals from Ethics Committee and Israeli Ministry of Health for the Company’s study with its proprietary SCI-210 treatment…
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI–2620…
Paratek Pharmaceuticals Announces Inclusion of NUZYRA® (omadacycline) in China’s National Reimbursement Drug List (NRDL)
National Healthcare Security Administration Adds NUZYRA to NRDL for Treatment of Community-Acquired Bacterial Pneumonia and…
Datavant Secures FedRAMP® Authorization, Trusted by Federal Agencies Through Privacy-Preserving Infrastructure
SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) — Datavant, the leader in enabling organizations to…
Plus Therapeutics Announces First Patient Dosed in ReSPECT-GBM Phase 2b Trial of Rhenium (186Re) Obisbemeda for Treatment of Recurrent Glioblastoma
Figure Initial treatment imaging from first patient treated in the ReSPECT-GBM Phase 2b trial AUSTIN,…
Blackbird.AI Launches Global Alliance Program to Bring Narrative & Risk Intelligence to Top Social and Media Technology Partners
Leading Narrative and Risk Intelligence Company Makes Cutting-Edge Analytics Platform Available to Partners Around the…
Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2
WILMETTE, Ill., Jan. 18, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage…
The Apache Software Foundation Announces Apache® Linkis™ as a Top-Level Project
Computation middleware layer facilitating computation governance problems in complex distributed environments has more than 2.7K…
Krystal Biotech Receives European Commission Orphan Designation for KB407 for the Treatment of Cystic Fibrosis
PITTSBURGH, Jan. 18, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a…
Melissa Partners with TomTom for Geospatial Location Precision to Maximize Business Value of Global Customer Address Data
Best-of-breed address engine ensures restaurants are found, packages are delivered, and on-demand drivers find their…
Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
Abu Dhabi-based collaboration to focus on accelerating the development of new personalized medications using AI…
Ambassador Labs Simplifies Organizational Adoption of Kubernetes With New Product Releases
New capabilities available in Ambassador Edge Stack and Telepresence optimize performance of developer workflows across…
Flyhound Takes Off with Patented Missing Person Location Technology and Graduates from NEC X’s Venture Studio Program
Drone location technology finds people 100x faster than traditional methods PALO ALTO, Calif., Jan. 18,…
Infinidat Supercharges the Channel for 2023 with Expanded Partner Program Support
WALTHAM, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) — Infinidat, a leading provider of enterprise storage…
Nozomi Networks Labs Report Finds Ruin vs. Ransom Dominates 2022 Threat Landscape
Disruptive attacks on critical infrastructure continued in to the second half of 2022 targeting rail,…